Business
Patent granted for Project Wave
Patent granted for Project Wave.
About this update from Inspiration Healthcare Group Plc
[{"type":"text","content":"\n \n \n RNS Number : 4633H\n Inspiration Healthcare Group PLC\n 25 March 2020\n \n \n \n \n \n \n \n \n \n \n Inspiration Healthcare Group plc\n \n \n (\"Inspiration Healthcare\", the \"Company\" or the \"Group\")\n \n \n \n \n \n Patent granted for Project Wave\n \n \n \n \n \n Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, is pleased to announce that it has received confirmation that the technology for \"Project Wave\" has been granted a patent by the US Patent Office. \n \n \n Inspiration entered into a licence agreement in 2019 \n with a major US West Coast University to develop \"Project Wave\" a \n novel technology \n for a respiratory device designed for use in neonatal intensive care. \n \n \n Neil Campbell, Inspiration Healthcare's CEO commented, \"This is a big milestone, knowing we have greater IP protection gives us more confidence as we move the project forward. We continue to work diligently towards applying for a small clinical trial for this ground breaking technology which we hope to start in the summer.\"\n \n \n \n \n \n Enquiries:\n \n \n \n \n \n \n Inspiration Healthcare Group plc\n \n \n Neil Campbell, Chief Executive Officer\n \n \n Mike Briant, Chief Financial Officer\n \n \n \n \n Tel: 01455 840555\n \n \n \n \n \n \n \n \n \n Nominated Adviser & Broker \n \n \n Cenkos Securities plc \n \n \n Mark Connelly\n \n \n Stephen Keys\n \n \n Cameron MacRitchie\n \n \n \n \n Tel: 0207 397 8900\n \n \n \n \n \n \n \n \n \n Cadogan PR \n \n \n Alex Walters\n \n \n \n [email protected]\n \n \n \n \n \n Tel: 07771 713608\n \n \n \n \n \n \n \n \n \n About Inspiration Healthcare\n \n \n \n \n \n Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.\n \n \n \n \n \n \n Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with a...